ArticleJournal of medicinal chemistry2025

Discovery of Cell-Permeable Macrocyclic Cyclin A/B RxL Inhibitors that Demonstrate Antitumor Activity.

Andrew T Bockus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.